EquiP EHV 10 x 1 dose EU + Syringe Needle 21G x 1.5
Is the registration number of your country not listed? Then this product falls within the cascade control system. For more information, click here (please check the rules of your country, they may deviate).
In Stock
Vaccine for Equine Herpesvirus 1 and 4 (Rhino).
Composition
Equip EHV is a suspension for injection. Each 1.5 ml dose of Equip EHV contains:
Active substance:
Inactivated EHV type 1, strain 438/77……………..≥107.3 TCID50
Inactivated EHV type 4, strain 405/76……………..≥107.3 TCID50
Adjuvants:
Carbopol 934P…………………………………………………6 mg
Indication
For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1.
Dosage and administration
One 1.5 ml dose per horse to be administered by deep intramuscular injection. Shake well before use.
Shake well before use.
Primary course:
- A single dose should be administered from 5 to 6 months of age followed by a second injection after an interval of 4 to 6 weeks.
- In the event of increased infection risk, for example when a foal had consumed insufficient colostrum or there is a risk of early exposure to field infections with EHV-1 or EHV-4, an earlier vaccination may be given. In these circumstances, the foal should receive a single dose from 3 to 4 months of age, followed by the above mentioned full primary vaccination.
Booster:
- Following completion of the primary course, a single dose should be administered every 6 months
Use in pregnant mares:
- To reduce the incidence of abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th, 7th and 9th month of pregnancy with a single 1.5ml dose of each occasion.
Special precautions for storage
Store and transport refrigerated at +2°C to +8°C
Protect from light. Do not freeze.
Instructions for use
One 1.5 ml dose per horse to be administered by deep intramuscular injection. Shake well before use.
Primary course:
- A single dose should be administered from 5 to 6 months of age followed by a second injection after an interval of 4 to 6 weeks.
- In the event of increased infection risk, for example when a foal had consumed insufficient colostrum or there is a risk of early exposure to field infections with EHV-1 or EHV-4, an earlier vaccination may be given. In these circumstances, the foal should receive a single dose from 3 to 4 months of age, followed by the above mentioned full primary vaccination.
Booster:
- Following completion of the primary course, a single dose should be administered every 6 months.
Use in pregnant mares:
- To reduce the incidence of abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th, 7th and 9th month of pregnancy with a single 1.5ml dose of each occasion.
Inactivated EHV type 1, strain 438/77, Inactivated EHV type 4, strain 405/76 and Carbopol 934P